OUR PRODUCTS

MOBILE APPS

GENERAL INFO

NTLA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Intellia Therapeutics (NTLA) Earnings Date & Reports

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NTLA is expected to report earnings to rise 1.67% to -99 cents per share on November 06

Intellia Therapeutics NTLA Stock Earnings Reports

Q3'25

Est.

$-1.00

Q2'25

Beat

by $0.05

Q1'25

Beat

by $0.17

Q4'24

Beat

by $0.07

Q3'24

Beat

by $0.05

The last earnings report on August 07 showed earnings per share of -98 cents, beating the estimate of -102 cents. With 569.74K shares outstanding, the current market capitalization sits at 1.16B.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+29%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

NTLA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NTLA
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NTLA showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of proprietary, potentially curative therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

40 Erie Street

Phone

+1 857 285-6200

Employees

526

Web

https://www.intelliatx.com